Geriatric Healthcare Specialist East Liverpool OH

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment.

Nevedita Saigal, MD
16687 Saint Clair Ave
East Liverpool, OH
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Maulana Azad Med Coll, Univ Of Delhi, New Delhi, Delhi, India
Graduation Year: 1997

Data Provided by:
Mark Howard Overton, MD
(724) 378-6565
Monaca, PA
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Or Hlth Sci Univ Sch Of Med, Portland Or 97201
Graduation Year: 1981

Data Provided by:
Susan Elaine Berner
(937) 681-5740
7792 Misty Shore Dr
West Chester, OH
Specialty
Geriatric Medicine

Data Provided by:
Naveena Nelson
(513) 585-9384
3200 Burnet Ave
Cincinnati, OH
Specialty
Geriatric Medicine

Data Provided by:
Sally L Brooks, MD
(513) 336-3090
MB2-535 4361 Irwin Simpson Rd
Mason, OH
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Marshall Univ Sch Of Med, Huntington Wv 25755
Graduation Year: 1988

Data Provided by:
Shantanu Saraswat, MD
(330) 386-4215
15122 Sprucevale Rd Apt A
East Liverpool, OH
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Male
Education
Medical School: Maulana Azad Med Coll, Univ Of Delhi, New Delhi, Delhi, India
Graduation Year: 1997

Data Provided by:
Paul Robert Moyer, MD
(215) 343-4388
77 E Woodbury Dr
Dayton, OH
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Pa Sch Of Med, Philadelphia Pa 19104
Graduation Year: 1967

Data Provided by:
Patrick K Murray
(216) 778-8529
2500 Metrohealth Dr
Cleveland, OH
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Allison Jay Batchelor
(740) 593-2482
142 Parks Hall
Athens, OH
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Esmeralda C Espino, MD
(330) 759-2679
32 Goldie Rd
Youngstown, OH
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Female
Education
Medical School: Univ Of Santo Tomas, Fac Of Med And Surg, Manila, Philippines
Graduation Year: 1963

Data Provided by:
Data Provided by:

Food for Thought

Provided by: 

By Kris Kucera

Rarely does an extended family get a free pass from Alzheimer’s disease or diabetes mellitus. On the surface, these two afflictions appear totally unrelated —Alzheimer’s (AD), Mother Nature’s cruel version of identity theft; and diabetes, the glucose-metabolism disorder that affects both young and old alike. However, new research indicates that the two diseases behave in a similar manner.

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment. This, they say, suggests that a form of diabetes, tentatively dubbed type 3, leads to AD.

Type 1 diabetes results from a severe or complete lack of insulin, a hormone made in the pancreas that controls blood sugar. Type 2, dubbed adult onset diabetes (although these days it occurs in teenagers and even younger kids), also stems from a dearth of insulin, or insulin resistance —the existing insulin molecules cannot deliver glucose through the cells’ membranes. Surprisingly, the researchers found a new form of insulin, produced in the brain, and they believe that, over time, decreasing levels of this “brain insulin” and other insulin-related proteins ultimately precipitate AD. While levels of brain insulin have no known affect on a body’s overall blood sugar, scientists have long recognized that diabetes patients are more likely to develop AD than those without the disease.

Skeptics of the Brown team’s findings argue that our brains produce so little insulin in the first place, reduced levels of the hormone can’t possibly play a significant role in AD. Regardless, the new data show that AD may be a neuroendocrine disorder, thus increasing the possibility for more effective treatments. And that gives hope to all of us who may one day be touched, directly or indirectly, by the merciless hand of AD.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...